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A mesophilic actinomycete strain designated as PB-52 was isolated from soil samples
of Pobitora Wildlife Sanctuary of Assam, India. Based on phenotypic and molecular
characteristics, the strain was identified as Nocardia sp. which shares 99.7% sequence
similarity with Nocardia niigatensis IFM 0330 (NR_112195). The strain is a Gram-positive
filamentous bacterium with rugose spore surface which exhibited a wide range
of antimicrobial activity against Gram-positive bacteria including methicillin-resistant
Staphylococcus aureus (MRSA), Gram-negative bacteria, and yeasts. Optimization for
the growth and antimicrobial activity of the strain PB-52 was carried out in batch culture
under shaking condition. The optimum growth and antimicrobial potential of the strain
were recorded in GLM medium at 28◦C, initial pH 7.4 of the medium and incubation
period of 8 days. Based on polyketide synthases (PKS) and non-ribosomal peptide
synthetases (NRPS) gene-targeted PCR amplification, the occurrence of both of these
biosynthetic pathways was detected which might be involved in the production of
antimicrobial compounds in PB-52. Extract of the fermented broth culture of PB-52
was prepared with organic solvent extraction method using ethyl acetate. The ethyl
acetate extract of PB-52 (EA-PB-52) showed lowest minimum inhibitory concentration
(MIC) against S. aureus MTCC 96 (0.975µg/mL) whereas highest was recorded against
Klebsiella pneumoniae ATCC 13883 (62.5µg/mL). Scanning electron microscopy (SEM)
revealed that treatment of the test microorganismswith EA-PB-52 destroyed the targeted
cells with prominent loss of cell shape and integrity. In order to determine the constituents
responsible for its antimicrobial activity, EA-PB-52 was subjected to chemical analysis
using gas chromatography-mass spectrometry (GC-MS). GC-MS analysis showed the
presence of twelve different chemical constituents in the extract, some of which are
reported to possess diverse biological activity. These results confirmed that the presence
of bioactive constituents in EA-PB-52 could be a promising source for the development of
potent antimicrobial agents effective against wide range of microbial pathogens including
MRSA.
Keywords: Nocardia sp., antimicrobial activity, microbial pathogens, biosynthetic genes, culturing conditions,
SEM, GC-MS
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INTRODUCTION
The discovery of antibiotics like penicillin and other
antimicrobial agents to treat infectious diseases has
revolutionized the field of medicine in the mid-twentieth
century. These discoveries have led to the development of
improved antibiotics with a hope to serve humanity well (Walsh,
2003). However, due to overuse or misuse of antibiotics over a
prolonged period, most of the pathogens have become resistant
to the antibiotic therapy. These pathogens have accumulated a
large number of resistance elements encoded by genes found
both within the genome and plasmids, greatly limiting the
therapeutic options (Wright, 2012). Thus, there is an immense
need for the discovery and development of new antibiotics
to effectively target these deadly pathogens that cause life-
threatening infections. Actinomycetes are one of the most
efficient groups of natural bioactive metabolite producers such as
antibiotics, enzyme inhibitors, immunomodifiers, plant growth
promoting substances, and many other compounds useful
to mankind (Fiedler et al., 2004; Shivlata and Satyanarayana,
2015). Among actinomycetes, around 75% of commercially
useful antibiotics such as ivermectin, tetracycline, streptomycin,
nystatin etc. are produced by the dominant genus Streptomyces
(Miao and Davies, 2010). But, in the past two decades, there
has been a decline in the discovery of novel metabolites from
Streptomyces as culture extracts usually yield disappointingly
high number of previously described molecules (Qin et al.,
2009; Aouiche et al., 2011). As such, new sources of bioactive
metabolites from another group of actinomycetes, known
as rare actinomycetes from different ecological niches have
promoted recent advances in the discovery of new antibiotic
molecules (Lazzarini et al., 2000; Lee et al., 2014; Azman
et al., 2015; Nimaichand et al., 2015). The genus Nocardia,
Saccharopolyspora, Micromonospora, Streptosporangium,
Streptoverticillium, Actinoplanes, and Actinomadura are
considered as the rare group of actinomycetes. It is because these
microbes are difficult to isolate and maintain under conventional
conditions (Berdy, 2005). Amongst the rare actinomycetes,
numerous interesting biologically active compounds have been
reported from the genus Nocardia such as nargenicin (Celmer
et al., 1980), transvalencin (Hoshino et al., 2004), nocardithiocin
(Mukai et al., 2009) etc.
Nocardia is a genus under the family Nocardiaceae of order
Corynebacteriales within the class Actinomycetes (Goodfellow
et al., 2012). The genus was first proposed by Trevisan (1889)
and was named in honor of Edmond Nocard, who in 1888
described the first species (Kageyama et al., 2004a). Nocardia is
a Gram-positive, aerobic, filamentous branching bacillus that is
partially acid fast and ∼86 species have been reported in the
genus Nocardia (Brown-Elliott et al., 2015). It is represented by
a list of chemical markers, including the presence of mycolic
acids, meso-DAP, galactose, and arabinose and DNA G + C
content of 63–72% (Goodfellow, 1992). However, little attention
has been paid toNocardia fromwhere we continue our interest to
extract biologically active compounds from this group of bacteria.
They are prominent for their ability to produce a wide variety of
biologically active compounds; however, some are also known to
be opportunistically pathogenic to humans and animals (Chun
and Goodfellow, 1995).
The plausibility of finding new bioactive molecules from
Nocardia could be increased by shifting the search from routinely
explored ecological niches to unexplored ones (Manikkam
et al., 2014). The poorly explored environments contain
highest populations of actinomycetes with valuable antimicrobial
secondary metabolites as reported by Ara et al. (2007). Isolation
of microorganisms from poorly explored areas of the world
like Jordan (Saadoun and Gharaibeh, 2003), Antarctica (Lee
et al., 2012), and certain ecological niches of Northeast India
(Bordoloi et al., 2001; Debnath et al., 2013) reflects that these
habitats should be carefully explored for novel microorganisms
and their valuable bioactive products. Northeast India is a part
of the Indo-Burma mega-biodiversity hotspot (Myers et al.,
2000). The influence of the local environment in the biodiversity
hotspots might result in the evolution of novel secondary
metabolic pathways in organisms (Glover, 1995). Pobitora
Wildlife Sanctuary of Assam is largely an unscreened forest
ecosystem and thus an unexplored source of actinomycetes and
biologically active secondary metabolites. Many actinomycetes
from forest ecosystems are known to produce polyketides
and non-ribosomal peptides by type-I and type-II polyketide
pathways and non-ribosomal peptide synthase pathways which
are the hallmark of secondary metabolites production in this
group of bacteria (Passari et al., 2015).
Our continuous screening for new bioactive metabolites from
rare actinomycetes resulted in the isolation of a promising
Nocardia strain designated as PB-52 from the soil samples of
Pobitora Wildlife Sanctuary of Assam, India. This sanctuary
(38.8 sq km) lies in the sub-tropical zone and is situated in
the flood plains of river Brahmaputra in Assam, India. In this
work, we aimed to investigate the antimicrobial biosynthetic
potential of PB-52 strain against a wide range of microbial
pathogens. Optimization of different culture conditions like
fermentation media, temperature, pH and period of incubation
was performed to facilitate improved growth and antimicrobial
activity of the strain. To evaluate the antimicrobial potency of
ethyl acetate extract of PB-52 (EA-PB-52), various techniques like
MIC determination against microbial pathogens, rate kill assay,
interaction with the test microbial pathogens by SEM analysis
was performed. The chemical constituents present in EA-PB-
52 were further identified using GC-MS. The outcome of this
research lays the foundation for performing in-depth studies
focusing on the development of potent antimicrobial agents
effective against a broad range of disease-causing microbial
pathogens including methicillin-resistant Staphylococcus aureus
(MRSA) and Candida albicans.
MATERIALS AND METHODS
Sampling Site and Sample Collection
Soil samples were collected in the month of April, 2013 from
varied locations of Pobitora Wildlife Sanctuary (26◦12′ to
26◦16′N and 91◦58′ to 92◦05′E) of Assam, India. The Sanctuary
experiences semi-dry hot climate in summer (37–39◦C) and cold
in winter (6–7◦C) with an average humidity of 75% and annual
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rainfall of 1500–2600mm. The habitat comprises of alluvial
grassland with hilly forests. Soil samples each weighing ∼50 g
was collected randomly from 5 to 20 cm depth after removing
the upper surface layer of the top soil. The samples were
transferred aseptically in sterile zip-lock bags and transported to
the laboratory on the same day.
Isolation of the Actinomycete Strain
During the screening of actinomycetes from soil samples,
PB-52 strain was isolated by serial dilution technique in
actinomycetes isolation agar medium (Himedia, India) amended
with rifampicin (2.5µg/mL) and amphotericin B (75µg/mL)
after incubation at 28◦C for 7–10 days (Thakur et al., 2007).
The pure culture of the isolate was sub-cultured on GLM agar
medium (Yeast extract, 3 g; malt extract, 3 g; peptone Type I,
5 g; starch, 10 g; agar, 20 g; distilled water, 1000mL; pH 7.4) and
preserved in 15% glycerol at−80◦C for future use.
Identification and Characterization of the
Actinomycete Strain
Cultural Characteristics
The cultural characteristic of PB-52 strain was examined by
growing the strain in different culture media. Micromorphology
of the strain was examined by using cover slip insertion method
(Williams et al., 1989) on GLM medium. The morphology and
ornamentation of the spore chain was observed by scanning
electron microscopy (Kumar et al., 2011). Utilization of carbon
and nitrogen was determined by growth of the strain on ISP
Medium No. 9 supplemented with 1% carbon and 1% nitrogen
sources respectively at 28◦C. Temperature range (15–45◦C), pH
range (4–11) and NaCl tolerance for growth (1–5% NaCl, w/v)
was determined on ISP Medium No. 4 (Shirling and Gottlieb,
1966). Hydrolysis of starch, cellulose, casein, tween 20, tween 80,
liquefaction of gelatin, nitrate reduction and other biochemical
tests were assessed by following the methods of Gordon et al.
(1974). Whole-cell hydrolysates were determined according to
Lechevalier and Lechevalier (1970). Sensitivity and resistance of
PB-52 strain to nineteen standard antibiotics were detected by
disc diffusion method (Kumar V. et al., 2014a).
Molecular Identification
DNA Extraction
Genomic DNA was isolated according to Sambrook and Russell
(2001) with slight modifications. For isolation of genomic DNA,
PB-52 strain was grown in GLM broth on a rotary shaker
(150 rpm) at 28◦C, pH 7.4 for 4 days. The cells were harvested by
centrifugation (8000 rpm, 5min), washed two times with sterile
water and suspended in 800µL lysis buffer (100mM Tris-HCl,
20mM EDTA, 250mM NaCl, 2% SDS and 1 mg/mL lysozyme).
2µL RNase was added and the sample was incubated at 37◦C for
3 h. 2µL proteinase K was added to the sample and incubated
at 65◦C for 30min. 800µL phenol, chloroform (1:1) was added
and centrifuged (12,000 rpm, 5min). The upper aqueous layer
was collected, mixed with equal volume of chloroform, isoamyl
alcohol (24:1) and centrifuged (12,000 rpm, 5min). Again, the
upper layer was collected, mixed with 0.1 volume sodium acetate
along with 2 volume 96% ethanol and incubated at −20◦C
for 1 h and centrifuged (12,000 rpm, 15min). The pellet was
washed first with 300µl 70% ethanol and then with 90% ethanol
(8000 rpm, 10min each). The pellet was air dried and suspended
in 30µL TE buffer (pH 7.7). DNA was analyzed by 1% agarose
gel electrophoresis.
PCR Amplification
16S rRNA gene was amplified using universal eubacterial primer
set, 27F (5′-AGA GTT TGA TCC TGG CTC AG-3′), and
1492R (5′-GGT TAC CTT GTT ACG ACT T-3′) (Weisburg
et al., 1991). PCR reactions were performed in Proflex PCR
System (Applied Biosystems, USA) in a total volume of 50µl
reaction mixture containing 50 ng template DNA, 1X Taq DNA
polymerase buffer, 1.5mM MgCl2, 0.2mM of each dNTP, 1 U
Taq DNA polymerase enzyme and 0.2µM of each primer. The
thermal cycling conditions were programmed as follows: initial
denaturation at 94◦C for 5min; followed by 35 cycles at 94◦C for
30 s, 52◦C for 30 s, 72◦C for 1min and final extension at 72◦C for
10min. The amplified products were determined by 1.8% (w/v)
agarose gel electrophoresis. The amplified products were further
purified usingGenElute PCRClean-UpKit (SigmaAldrich, USA)
and the purified PCR products were sequenced by automated
DNA sequencer with specific primers using the facility at Xcelris
Genomics Lab Ltd. (Ahmedabad, India).
Phylogenetic Analysis
Identification of phylogenetic neighbors and calculation of
pairwise sequence similarities of 16S rRNA gene of PB-52 strain
were carried out using BLASTN (Altschul et al., 1990) and
EzTaxon server (http://www.eztaxon.org/; Kim et al., 2012). Top
14 reference sequences with highest scores were selected for
multiple sequence alignment which was performed by CLUSTAL
W program (Thompson et al., 1997). The phylogenetic tree was
constructed by neighbor-joining method (Saitou and Nei, 1987)
using MEGA version 4.0 (Tamura et al., 2007). The support of
each clade was determined by bootstrap analysis performed with
1000 replications (Felsenstein, 1985). The GenBank accession
number for the partial 16S rRNA gene sequence of PB-52 strain
is KM406386.
Evaluation of Antimicrobial Activity of
PB-52 Strain
Test Microorganisms
The following test microorganisms were used for the experiment.
Gram-positive bacteria: S. aureus MTCC 96, S. aureus MTCC
3160, MRSA ATCC 43300, S. epidermidis MTCC 435, Bacillus
subtilis MTCC 441, B. cereus MTCC 1272, B. megaterium
MTCC 8075, Micrococcus luteus MTCC 1538; Gram-negative
bacteria: Escherichia coli MTCC 40, E. coli MTCC 739, Serretia
marcescens MTCC 97, Klebsiella pneumoniae MTCC 3384, K.
pneumoniae ATCC 13883, Pseudomonas aeruginosa MTCC 741,
P. aeruginosa MTCC 424, P. aeruginosa MTCC 2582, Proteus
vulgaris MTCC 426; Yeast: C. albicans MTCC 227, C. tropicalis
MTCC 2208 and C. albicans ATCC 10231. All the MTCC strains
were purchased from Microbial Type Culture Collection, CSIR-
Institute of Microbial Technology, Chandigarh, India and ATCC
cultures were purchased from HiMedia, Mumbai. The bacterial
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strains were cultured in nutrient agar medium at 37◦C and yeasts
strains were cultured on Sabouraud dextrose medium at 25◦C.
The test organisms were preserved at −70◦C in glycerol stock
vials for further study.
Antimicrobial Activity Assessment and Media
Optimization
Strain PB-52 was screened for in vitro antimicrobial activity
against test microorganisms by conventional spot inoculation
method (Shomurat et al., 1979) onGLMagarmedium after 8 days
of incubation at 28◦C. The inhibition zone was observed after 24–
48 h incubation at 37◦C for bacteria and at 25◦C for yeasts. Each
experiment was conducted in three replicates and the average
size of PB-52 colony diameter and mean value of inhibition zone
diameter (mm± SD) of test microorganisms was calculated.
The selection of best culture medium for growth and
antimicrobial activity of PB-52 was performed by growing
the strain in different growth media such as GLM broth,
Thronton’s broth (K2HPO4, 1 g; KNO3, 0.5 g; MgSO4.2H2O,
0.2 g; CaCl2.H2O, 0.1 g; NaCl, 0.1 g; FeCl3, 0.01 g; aspargine, 0.5 g;
distilled water, 1000mL), CSPY-ME broth, Actinomycetes broth
and nutrient broth. The strain PB-52 was grown with continuous
shaking on a rotary shaker (150 rpm) at 28◦C, pH 7.4 for 8 days.
Antimicrobial potential was evaluated against S. aureus MTCC
96 by disc diffusion method (Bauer et al., 1966) since this test
organism was found to be more sensitive during antimicrobial
evaluation by spot inoculation method. The experiment was
repeated three times and its mean value was recorded.
Crude extract of PB-52 strain was recovered from the culture
filtrate by solvent extraction using ethyl acetate in 1:1 ratio
(v/v). The ethyl acetate extract of PB-52 (EA-PB-52) obtained
by evaporation of ethyl acetate was prepared by dissolving
it in 10% dimethyl sulphoxide (DMSO) at a concentration
of 1 mg/mL prior to antimicrobial bioassay. 20µL EA-PB-
52 was loaded on to sterile discs (6mm diameter) placed on
nutrient agar plates spread with bacterial test organisms (0.5
McFarland turbidity standards). Similarly, the experiment was
conducted with Candida species on sabouraud dextrose agar
plates. 10% DMSO loaded disc was used as a negative control
while rifampicin (20µg/disc) for bacteria and amphotericin B
(30µg/disc) for Candida species served as positive controls.
Antimicrobial activity was observed after 24–48 h incubation at
37◦C for bacteria and at 25◦C for yeasts. Each experiment was
conducted in three replicates and the mean value of inhibition
zone diameter was calculated. Among all the different liquid
media evaluated for antimicrobial activity, GLM was found to be
the best medium for PB-52 strain; hence, it was selected as the
production medium for further studies.
Effect of Temperature, pH and Incubation
Period on Growth and Antimicrobial
Activity
GLM medium was inoculated with PB-52 strain to study the
growth response and antimicrobial activity at different range of
temperatures from 20 to 40◦C at 150 rpm for 8 days at pH 7.4. To
study the effect of pH, different ranges of acidic to alkaline pH-
values (5–10) were used for the growth and antibiotic production
in GLM broth at 28◦C for 8 days. Similarly, incubation periods
were observed up to 12 days to determine the optimum growth
and antibiotic production of PB-52 in GLM broth at 28◦C, pH
7.4. The antimicrobial activity of PB-52 was assessed against S.
aureusMTCC 96 by disc diffusion method (El-Gendy et al., 2008;
Thakur et al., 2009) in terms of diameter of inhibition zone.
PCR Amplification and Sequencing of
Biosynthetic Genes of PB-52 Strain (PKS-I
and NRPS)
Degenerate primers K1F (5′-TSA AGT CSA ACA TCG GBC
A-3′) and M6R (5′- CGC AGG TTS CSG TAC CAG TA-3′)
were used for amplification of PKS-I ketosynthase and methyl-
malonyltransferase domain sequences and primers A3F (5′-GCS
TAC SYS ATS TAC ACS TCS GG-3′) and A7R (5′-SAS GTC
VCC SGT SCG GTA S-3′) were used for amplifications specific
for NRPS adenylation domain sequences (Ayuso-Sacido and
Genilloud, 2005). PCR reactions were performed in Proflex PCR
System (Applied Biosystems, USA) in a final volume of 50µl
consisting of template DNA (50 ng), 1X Taq DNA polymerase
buffer, MgCl2(1.5mM), each dNTP (0.2mM), 1 U Taq DNA
polymerase enzyme and each primer (0.2µM). For increasing the
specificity, touchdown PCR was performed for the amplification
of PKS-I genes. In touchdown PCR, annealing temperature was
set 10◦C above the expected annealing temperature (56.8◦C)
and decreased by 1◦C every second cycle until a touchdown
of 46.8◦C, at which temperature 25 additional cycles were
carried out. Denaturation was carried out at 94◦C for 1min,
primer annealing was performed at the appropriate temperature
(46.8◦C) for 1min, and primer extension at 72◦C for 2min
followed by the final extension at 72◦C for 10min. The thermal
cycling conditions for the amplification of NRPS genes were
programmed as: initial denaturation at 94◦C for 5min; followed
by 35 cycles at 94◦C for 1min, 63◦C for 1min, 72◦C for 2min,
and final extension at 72◦C for 10min.
The amplified products were purified byGenElute PCRClean-
Up Kit (Sigma Aldrich, USA). The purified PCR products were
sequenced by automated DNA sequencer with the specific PKS-
I and NRPS primers using the sequencing facility at First BASE
Laboratories, Malaysia. The resultant sequence was analyzed
using BLAST N. The PKS-I (1040 bp fragment) and NRPS (647
bp fragment) gene sequences were deposited to GenBank under
the accession number KU721843 and KU721842, respectively.
Determination of Minimum Inhibitory
Concentration (MIC) of EA-PB-52
MIC was determined as illustrated by the Clinical Laboratory
Standards Institute (CLSI; 2012) and Andrews (2001) with slight
modifications using broth dilution method. An inoculum of
1 × 105 CFU/mL of test microorganisms (log phase culture)
was added to 5mL of Mueller Hinton broth (for bacterial test
organisms) and Sabouraud dextrose broth (for yeasts) in different
test tubes and incubated at room temperature for 24–48 h. EA-
PB-52 was dissolved in 10% DMSO (1000µg/mL) and two-fold
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serial dilutions of the extract was prepared for MIC tests (62.5–
0.975µg/mL). MIC was determined after 48 h of incubation of
the test microorganisms in the presence of EA-PB-52. 10µl
of the test microorganisms were removed from each tube and
spread on Mueller Hinton agar plates/sabouraud dextrose agar
plates. The growth of test organisms was observed after 24 h
of incubation at 37◦C for bacteria and 25◦C for yeasts. MIC
was recorded as the lowest concentration of the antimicrobial
compoundwhich inhibits the visible growth of the inoculated test
microorganisms completely after 24–48 h. Control was prepared
using 10% DMSO without antimicrobial agent which should be
turbid (negative control) while control with standard antibiotic
such as rifampicin, streptomycin, and amphotericin B should be
clear (positive control).
Rate of Kill Assay of EA-PB-52
Antimicrobial assay for the rate of killing of test microorganisms
by EA-PB-52 was done in accordance with the description
of Eliopoulos and Moellering (1996) using modified plating
technique. EA-PB-52 was inoculated into 10mL Mueller Hinton
broth for bacterial test microorganisms and Sabouraud dextrose
broth for yeasts at ½× MIC, 1 × MIC and 2 × MIC.
Broth with EA-PB-52 at the test concentrations without the
test microorganisms and broth without EA-PB-52 with test
organisms served as controls. 1 × 105 CFU/mL inoculum was
used to inoculate 10mL of both control and test bottles. The
bottles were incubated at 37◦C for bacteria and 25◦C for yeasts
on an orbital shaker at 150 rpm. 100µl aliquot was removed from
the culture medium after 0, 4, and 8 h incubation to determine
CFU/mL by the plate count technique (Cruickshank et al., 1975)
by plating 25µl of each of the dilutions. After incubation,
emergent colonies were counted, CFU/mL was determined and
compared with the count of the control culture without EA-
PB-52. 10% DMSO was used as control. The experiments were
conducted in replicates and the mean value was obtained. The
results were expressed as positive or negative log10 values (Baltch
et al., 1998).
Interaction of EA-PB-52 with Test
Microorganisms by SEM Analysis
EA-PB-52 with strong antimicrobial activity was further studied
for its possible effects on targeted cells of P. aeruginosa MTCC
741 and C. albicans MTCC 227 by SEM according to Supaphon
et al. (2013) with slight modifications. Test microorganisms were
grown overnight and then treated with 1 × MIC EA-PB-52.
Cells were harvested after 24 h of incubation and washed with
phosphate buffered saline (PBS), pH 7.4. The cells were fixed
with 2.5% (v/v) glutaraldehyde in PBS for 2 h and dehydrated in
series of increasing concentrations of acetone (30–100%, v/v) for
10min. The cells were dried for 30–45min and mounted onto
steel stub with double-sided carbon tape. Samples were coated
with a film of gold-palladium alloy under vacuum and scanned
under scanning electron microscope (Zeiss Sigma VP, Germany).
GC-MS Analysis of EA-PB-52
Identification of the chemical compounds present in EA-PB-52
was analyzed using GC-MS as previously described (Ser et al.,
2015b; Sun et al., 2015) with slight modifications. The sample was
dissolved in spectroscopy-grade methanol and filtered through
0.2µm filter. GC-MS analysis was performed on Shimadzu GC
2010 plus with triple quadrupole MS (TP-8030) fitted with
EB-5 MS column (length- 30 m, thickness–0.25µm, internal
diameter–25mm). The oven programme started at 40◦C, held for
5min and then ramped at 10◦C/min to 280◦C, held for 10min
and then again raised to 285◦C at 5◦C/min and finally held for
10min. Sample was injected at 300◦C using helium as carrier gas
(1mL/min), split at the ratio of 1:20. The mass spectrometer was
operated in the electron ionization (EI) mode at 70 eV with a
continuous scan from 45 to 600m/z. The peaks were identified
by matching the mass spectra with the National Institute of
Standards and Technology (NIST, USA) library.
Detection of Polyenic or Non-polyenic
Antimicrobial Activity of EA-PB-52
The polyene like activity of EA-PB-52 was determined by
ergosterol agar plate method by using ergosterol as the reversal
agent to test for its ability to reverse the inhibition of C. albicans
MTCC 227 caused by the metabolite (Thakur et al., 2007). EA-
PB-52 was dissolved in methanol and its absorption spectrum
was scanned in the UV-vis region (200–800 nm) by using a
Nanodrop 2000c UV-vis spectrophotometer (Thermo Fisher
Scientific, USA).
Statistical Analysis
All experiments were performed in biological triplicate and
repeated for three times. The data was expressed as the mean ±
standard deviation of mean of the three replicates. Duncan’s
multiple range test was performed to compare that the sample
means differ significantly from each other at a significant level of
P < 0.05 (Gomez and Gomez, 1984).
RESULTS
Characterization of PB-52 Strain
Actinomycete strain PB-52 isolated from soil samples of Pobitora
Wildlife Sanctuary of Assam, India, was aerobic, Gram-positive,
and filamentous in nature (Figure 1A). The branched vegetative
hyphae were light brown in color while aerial mycelium with
orange color was sparse with a patchy distribution. The strain
produced faint brown soluble pigment after incubation for more
than 20 days at 28◦C. SEM analysis revealed that the aerial
mycelia formed long, straight to rectiflexibiles spore chains with
rugose spore surface (Figure 1B). The cultural characteristics of
PB-52 strain in different media are shown in Table 1, where
the strain showed good growth on all the media except Mueller
Hinton agar and Omeliansky’s agar medium. The strain was
found to grow between the temperature range of 20–42◦C,
pH 5–11 with optimal growth temperature at 28◦C, pH 7.4,
and in the presence of upto 5% NaCl (w/v) with optimum at
1–3% NaCl. The morphological, physiological, and biochemical
characteristics of PB-52 and its antibiotic sensitivity are shown
in Table 2. The whole-cell hydrolysates of PB-52 were rich in the
meso-diaminopimelic acid along with galactose and arabinose as
characteristic whole cell sugars.
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Partial 16S rRNA gene sequence (1259 nucleotides) of PB-52
strain was determined and submitted to NCBI GenBank database
under the accession number KM406386. The strain showed
highest 16S rRNA gene sequence similarities with Nocardia
niigatensis IFM 0330 (NR_112195; 99.7%). The phylogenetic
tree also indicated its closest similarity to N. niigatensis based
on Neighbor-joining method (Figure 2). The phenotypic and
genomic data indicated that PB-52 strain represented a strain
of the genus Nocardia for which the strain was referred to as
Nocardia sp. strain PB-52.
Antimicrobial Potential of PB-52 Strain
During the screening of PB-52 strain for drug discovery by spot
inoculation method in GLM agar medium, it was observed that
PB-52 exhibited excellent activity by inhibiting Gram-positive
FIGURE 1 | Microscopic view showing spore chain of Nocardia sp.
PB-52 on GLM agar (A) Micro morphology using cover slip insertion
method; (B) Scanning electron micrograph view.
bacteria, Gram-negative bacteria and yeasts. The average size of
the colony of PB-52 in GLMmediumwas (7± 2)mm in diameter
after 8 days of incubation at 28◦C. The maximum mean value
of inhibition zones (mm ± SD) was found against S. aureus
MTCC 96 (inhibition zone diameter of 36 ± 0.8), followed by
TABLE 1 | Cultural characteristics of Nocardia sp. PB-52 on different
media.
Medium Aerial
mycelium
color
Substrate
mycelium
color
Diffusible
pigment
Growth
Actinomycetes isolation
agar
Brown Dark brown − +++
Streptomyces agar Light orange Orange − ++
GLM medium Orange Light brown Faint Brown +++
CSPY-ME medium Pink Brown − +++
Mueller Hinton Agar Light brown Brown − +
Nutrient agar White Cream − ++
Sabouraud Dextrose
Agar
Orange Cream − ++
Thronton’s medium Orange Brown − ++
Omeliansky’s agar White Brown − +
ISP 2 Pink Orange − +++
ISP 3 White Brown − ++
ISP 4 White Cream − +++
ISP 7 Orange Cream − ++
+++, Good growth; ++, Moderate growth; +, Poor growth; −, No growth.
FIGURE 2 | Phylogenetic tree of Nocardia sp. PB-52 and the closest Nocardia species showing phylogenetic relationships based on the 16S rRNA
gene sequences using neighbor-joining method. Bootstrap percentages based on 1000 resamplings are listed at nodes, only values above 50% are given. Bar,
0.005 substitutions per nucleotide position.
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TABLE 2 | Morphological, physiological, and biochemical characteristics
of Nocardia sp. PB-52.
Characteristics Result
MORPHOLOGICAL
Aerial mycelium color Orange
Substrate mycelium color Brown
Diffusible pigment Faint brown
Melanin pigment –
Spore chain morphology Straight to rectiflexibiles
Spore surface Rugose
PHYSIOLOGICAL
Temperature range for growth 20–42◦C
Optimum temperature for growth 28◦C
pH range for growth 5–11
Optimum pH for growth 7.4
NaCl tolerance Up to 5%
BIOCHEMICAL
Gram reaction Positive
Utilization of
Glucose +
Fructose +
Arabinose −
Mannitol +
Inositol +
Adonitol +
Galactose −
Sucrose +
Xylose +
Lactose +
Maltose +
Starch +
Glycerol +
Erythritol −
Sorbitol −
Rhamnose −
Gluconate −
Carboxy methyl cellulose +
Citrate −
Urea +
Ammonium chloride +
Ammonium sulfhate +
Sodium nitrate +
Glycine +
Asparagine +
Casein −
Tween 20 −
Tween 80 +
Nitrate reduction +
Gelatin liquefaction −
Cell wall amino acids Meso-diaminopimelic acid
Cell wall sugars Arabinose, galactose
(Continued)
TABLE 2 | Continued
ANTIBIOTIC SENSITIVITY (µg/disc)
Vancomycin (30) S
Chloramphenicol (30) S
Oxacillin (1) R
Ciprofloxacin (5) S
Co-trimoxazole (25) R
Streptomycin (10) S
Methicillin (5) S
Ampicillin (10) R
Penicillin-G (10) S
Gentamicin (120) R
Nalidixic acid (30) S
Erythromycin (5) S
Norfloxacin (10) S
Amphotericin B (100) R
Clotrimazole (10) S
Fluconazole (25) R
Itraconazole (10) R
Ketoconazole (10) S
Nystatin (100) R
+, Positive for test; −, Negative for test; S for Sensitivity; R for Resistant.
FIGURE 3 | Effect of different culture media on growth and
antimicrobial activity assessed in terms of diameter of inhibition zone
by Nocardia sp. PB-52 (Test organism: S. aureus MTCC 96).
E. coli MTCC 40 (31 ± 1.2) and MRSA ATCC 43300 (30 ±
0.8). Maximum growth inhibition among yeast test pathogens
was observed in C. albicans MTCC 227 (27 ± 0.4). The detailed
antimicrobial profiles in GLMagarmedium are shown inTable 3.
Among the different liquid culture media evaluated for the
production of the bioactive compounds in shake flask condition,
GLM was found to be most appropriate for growth and
antimicrobial activity assessed in terms of diameter of inhibition
zone by PB-52 strain (Figure 3). The culture filtrate of PB-52
grown on GLM medium exhibited maximum zone of inhibition
against S. aureusMTCC 96 followed by the culture filtrate grown
on CSPY-ME broth while lowest activity was observed with the
one grown on nutrient broth. The antimicrobial activity of EA-
PB-52 along with the controls (10% DMSO as negative control
and standard antibiotics as positive control) against S. aureus
MTCC 96 and C. albicansMTCC 227 is shown in Figure 4.
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TABLE 3 | Antimicrobial activity and MIC (µg/mL) of Nocardia sp. PB-52 by broth dilution method.
Test microorganisms *Zone of inhibition (mm) MIC of EA-PB-52 (µg/mL) MIC of Rif (µg/mL) MIC of Strep (µg/mL) MIC of Amp B (µg/mL)
GRAM-POSITIVE BACTERIA
S. aureus MTCC 96 36k ±0.8 >0.975 >1.95 >6.25 NA
S. aureus MTCC 3160 29hij ±0.8 >1.95 >1.95 >12.5 NA
S. epidermidis MTCC 435 23de ±1.6 >7.81 >3.125 >6.25 NA
B. subtilis MTCC 441 28ghi ±0.8 >1.95 >1.95 >6.25 NA
B. cereus MTCC 1272 22d ±0.4 >7.81 >6.25 >12.5 NA
B. megaterium MTCC 8075 26fg ±0.4 >3.9 >3.12 >3.12 NA
M. luteus MTCC 1538 22d ±1.6 >7.81 >0.97 >6.25 NA
MRSA ATCC 43300 30ij ±0.8 >1.95 >25 >50 NA
GRAM-NEGATIVE BACTERIA
E. coli MTCC 40 31j ±1.2 >3.9 >6.25 >3.12 NA
E. coli MTCC 739 25ef ±0.4 >3.9 >50 − NA
S. marcescens MTCC 97 18b ±1.2 >31.2 >12.5 >3.12 NA
K. pneumoniae MTCC 3384 27fgh ±1.6 >1.95 >25 − NA
K. pneumoniae ATCC 13883 15a ±1.6 >62.5 >50 − NA
P. aeruginosa MTCC 741 29hij ±0.8 >1.95 >25 >25 NA
P. aeruginosa MTCC 424 19bc ±1.2 >15.6 − >12.5 NA
P. aeruginosa MTCC 2582 26fg ±0.8 >3.9 >50 >25 NA
P. vulgaris MTCC 426 17a ±0.8 >31.25 >25 >6.25 NA
YEAST
C. albicans MTCC 227 27fgh ±0.4 >1.95 NA NA >0.97
C. tropicalis MTCC 2208 23de ±0.2 >7.81 NA NA >0.48
C. albicans ATCC 10231 21cd ±1.6 >7.81 NA NA >1.95
*Zone of inhibition by spot inoculation method on GLM agar medium. Average size of colony of PB-52 in GLM agar was (7 ± 2)mm in diameter after 8 days of incubation at 28◦C.
Zone of inhibition values are given as mean ± SD (n = 3). Values having different superscripts (a-k) differ significantly (P < 0.05).
Rif, Rifampicin (antibacterial agent); Strep, Streptomycin (antibacterial agent); Amp B, Amphotericin B (antifungal agent); NA, not applicable; −, No activity.
FIGURE 4 | In-vitro antimicrobial activity of EA-PB-52 following disc
diffusion method against (A) S. aureus MTCC 96 (B) C. albicans MTCC
227 (i) 10% DMSO (negative control), (ii) 20µg/disc rifampicin (positive
control), (iii) 30µg/disc amphotericin B (positive control), (iv) 20µg/disc
EA-PB-52.
Effect of Cultural Parameters on Growth
and Antimicrobial Activity
The culture conditions for growth and antimicrobial evaluation
by PB-52 strain was studied on GLM medium. PB-52 displayed
a narrow range of incubation temperature for its good growth
and production of antibiotics. 28◦Cwas found to be the optimum
temperature for highest growth and maximum antimicrobial
activity by the strain (Figure 5). The organism appeared to be
FIGURE 5 | Effect of temperature on growth and antimicrobial activity
assessed in terms of diameter of inhibition zone by Nocardia sp. PB-52
(Test organism: S. aureus MTCC 96).
mesophilic in terms of its growth at optimum temperature.
However, poor growth and decreased antibiotic production were
evident at higher incubation temperature. The maximum growth
as well as highest antibiotic production was obtained at pH-
value of 7.4 (Figure 6). However, adverse growth and antibiotic
production were observed at pH-values above and below neutral.
Maximum incubation period of 8 days is required for best
growth and antibiotic production under shake flask conditions
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FIGURE 6 | Effect of pH on growth and antimicrobial activity assessed
in terms of diameter of inhibition zone by Nocardia sp. PB-52 (Test
organism: S. aureus MTCC 96).
FIGURE 7 | Effect of incubation period on growth and antimicrobial
activity assessed in terms of diameter of inhibition zone by Nocardia
sp. PB-52 (Test organism: S. aureus MTCC 96).
(Figure 7). Antimicrobial activity by PB-52 strain was assessed in
terms of diameter of inhibition zone.
Analysis of PKS-I and NRPS Genes
Polyketide synthase (PKS) and non-ribosomal peptide synthetase
(NRPS) are biosynthetic enzymes responsible for the production
of different classes of bioactive molecules in Actinomycetes
(Hodges et al., 2012). PCR amplification of PKS-I gene of the
strain PB-52 resulted in a band size of 1200–1400 bp fragments
(Figure 8A) using K1F/M6R primers corresponding to PKS-
I ketosynthase and methyl-malonyl-CoA transferase modules
of the polyketide synthase gene. Sequencing of the PKS-I
gene fragment yielded a sequence length of 1040 bp (NCBI
accession no. KU721843). PB-52 strain showed highest PKS-I
gene sequence similarities (89%) with Streptomyces olivoviridis
strain O855 clone 22 modular polyketide synthase gene (NCBI
accession no. FJ405974). The NRPS amplicon was found to
be 700 bp size (Figure 8B) using A3F/A7R specific primers
for NRPS genes targeting NRPS adenylation domain sequences.
Sequencing of the NRPS gene fragment yielded 647 bp sequence
length (NCBI accession no. KU721842). NRPS sequence of
PB-52 showed highest similarities (76%) to Streptomyces sp.
Sp080513GE-23 gene for non-ribosomal peptide synthetase
(NCBI accession no. AB492018). The closest similarity of PKS-I
and NRPS sequences of PB-52 to the closest relatives in GenBank
is shown in Table S1.
MIC of EA-PB-52
MIC values of EA-PB-52 ranging from 62.5 to 0.975µg/mL
were performed against all the test microorganisms by broth
dilution method. The quantitative efficiency of EA-PB-52 against
these organisms was estimated as MIC and it has got lowest
MIC against S. aureus MTCC 96 (0.975µg/mL) whereas
highest was recorded against K. pneumoniae ATCC 13883
(62.5µg/mL; Table 3). According to CLSI recommendations
for MIC, K. pneumoniae ATCC 13883 was found to be
resistant to EA-PB-52 (MIC: 62.5µg/mL) since ≤8µg/mL
was taken as susceptible, ≤16µg/mL as intermediate and
≥32µg/mL as resistant (CLSI, 2012). It was observed that
10% DMSO (control) had no inhibitory effect on the test
microorganisms.
Time-Kill Assay
The time-kill assay was conducted for EA-PB-52 against all
the test microorganisms. Table 4 shows the changes in the
log10 CFU/mL of viable colonies of the test microorganisms
following exposure to different concentration of EA-PB-52 which
is expressed in terms of log10 CFU/mL change. It is based
on the conventional bactericidal activity standard, i.e., 3 log10
CFU/mL or greater reduction in the viable colony count (Pankey
and Sabath, 2004). After incubating the test microorganisms for
4 h with 1 × MIC and 2 × MIC of EA-PB-52, the average
log reduction in the viable cell count ranged between −0.157
log10 and 1.897 log10 CFU/mL. While after 8 h of incubation,
the average log reduction in the viable cell count ranged
between −2.092 log10 and 0.864 log10 CFU/mL. After 4 h of
incubation of the test microorganisms with 1×MIC, the average
log reduction in the viable cell count ranged between 0.947 log10
and 1.897 log10 while incubating the test microorganisms with
2 × MIC resulted in the average log reduction in the viable cell
count ranging between−0.157 log10 and 0.891 log10. After 8 h of
incubation with 1×MIC resulted in average log reduction in the
viable cell count between 0.342 log10 and 0.864 log10 while 2 ×
MIC resulted in the average log reduction in the viable cell count
ranging between −2.092 log10 and −1.213 log10. The highest log
reduction in cell density with EA-PB-52 was observed in S. aureus
MTCC 96 (−2.092 log10 CFU/mL) followed by E. coli MTCC
40 (−1.917 log10 CFU/mL) and MRSA ATCC 43300 (−1.908
log10 CFU/mL), while least log reduction in cell density was
observed inK. pneumoniaeATCC 13883 (−1.213 log10 CFU/mL)
followed by P. vulgaris MTCC 426 (−1.325 log10 CFU/mL). No
inhibitory effect was observed with 10% DMSO (control) on the
test microorganisms.
SEM Analysis
Antibacterial and anti-candidal activity of the EA-PB-52 was
evaluated against P. aeruginosa MTCC 741 and C. albicans
MTCC 227 by SEM analysis. SEM study revealed that
treatment of the test microorganisms with 1 × MIC EA-
PB-52 showed considerable morphological alterations in the cells
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FIGURE 8 | Agarose gel electrophoresis of PCR amplified products of Nocardia sp. PB-52. (A) Selective amplification of PKS-I using K1F/M6R specific
primers; (B) Selective amplification of NRPS using A3F/A7R specific primers.
TABLE 4 | In vitro time-kill assessment of EA-PB-52 against the test microorganisms.
Test microorganisms log10 kill (1/2) × MIC log10 kill 1 × MIC log10 kill 2 × MIC
0 h 4 h 8 h 0 h 4 h 8 h 0 h 4 h 8 h
GRAM-POSITIVE BACTERIA
S. aureus MTCC 96 2.452 2.772 4.330 2.456 0.947 0.342 2.468 –0.157 –2.092
S. aureus MTCC 3160 2.510 3.245 3.998 2.487 1.263 0.582 2.433 0.422 –1.775
S. epidermidis MTCC 435 2.853 3.421 4.227 2.610 1.512 0.539 2.717 0.531 –1.717
B. subtilis MTCC 441 2.329 3.022 4.172 2.311 1.235 0.492 2.352 0.544 –1.842
B. cereus MTCC 1272 2.115 2.914 4.013 2.302 1.429 0.483 2.196 0.436 –1.741
B. megaterium MTCC 8075 2.277 3.510 4.734 2.256 1.197 0.548 2.290 0.282 –1.869
M. luteus MTCC 1538 2.314 3.219 3.816 2.334 1.315 0.513 2.105 0.587 –1.512
MRSA ATCC 43300 2.412 2.868 3.797 2.249 1.206 0.429 2.270 0.124 –1.908
GRAM-NEGATIVE BACTERIA
E. coli MTCC 40 2.212 2.842 3.714 2.368 1.191 0.404 2.292 –0.112 –1.917
E. coli MTCC 739 2.401 3.124 3.874 2.427 1.374 0.473 2.218 0.677 –1.880
S. marcescens MTCC 97 2.316 2.997 4.512 2.212 1.529 0.597 2.307 0.528 –1.563
K. pneumoniae MTCC 3384 2.312 3.046 4.147 2.299 1.434 0.501 2.333 0.648 –1.693
K. pneumoniae ATCC 13883 2.216 3.934 4.729 2.137 1.897 0.864 2.296 0.891 –1.213
P. aeruginosa MTCC 741 2.142 3.013 3.976 2.312 1.463 0.413 2.133 0.432 –1.436
P. aeruginosa MTCC 424 2.314 3.814 5.214 2.367 1.545 0.456 2.121 0.612 –1.517
P. aeruginosa MTCC 2582 2.202 2.889 4.318 2.311 1.385 0.567 2.273 0.418 –1.493
P. vulgaris MTCC 426 2.013 3.214 4.813 2.213 1.662 0.727 2.115 0.723 –1.325
YEAST
C. albicans MTCC 227 2.104 3.116 3.937 2.204 1.229 0.435 2.316 0.499 –1.865
C. tropicalis MTCC 2208 2.049 3.313 4.712 2.014 1.575 0.541 2.179 0.583 –1.630
C. albicans ATCC 10231 2.098 3.236 4.213 2.212 1.305 0.512 2.513 0.513 –1.518
including shrinkage and deformity leading to prominent
cell shape loss and integrity. The control cells treated
with 10% DMSO appeared smooth with intact cell surface
(Figure 9).
GC-MS Analysis
Chemical composition of EA-PB-52 was done using GC-MS.
Twelve chemical compounds were identified by comparison of
their mass spectra with the NIST library based on their retention
time, molecular weight, and molecular formula shown in Table 5
and the chemical structures were illustrated in Figure 10. The
peak area of the compound is directly proportional to its quantity
in EA-PB-52 (Figure S1).
Detection of Polyenic or Non-polyenic
Antimicrobial Activity of EA-PB-52
The ergosterol test of EA-PB-52 showing antimicrobial activity
indicated the absence of polyene class of antibiotics. The nature
of the metabolite was thus found to be non-polyene. The UV-
vis spectrum of the EA-PB-52 in methanol showed the presence
of three distinct peaks at 247, 260, and 296 nm where maximum
absorption peak was observed at 296 nm (Figure S2).
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TABLE 5 | Chemical compounds detected in EA-PB-52 by GC-MS analysis.
Compound name Similarity
(%)
RT MW Area (%) Nature of
compound
Activity References
(Z)-3-tridecene 95 18.27 182 5.14 Hydrocarbon No activity reported
3,5-bis
(1,1-dimethylethyl)-phenol
91 19.93 206 34.43 Phenolic compound No activity reported
(Z)-3-tetradecene 95 20.94 196 7.90 Hydrocarbon Antimicrobial Natarajan and Dhas, 2014
Dodecyl acrylate 96 22.13 240 6.01 Ester Antibacterial Manilal et al., 2009
2,4-di-t-butyl-6-nitrophenol 63 22.22 251 4.32 Phenolic compound Antimicrobial Gutierrez et al., 2009
Hexahydro-pyrrolo[1,2-
a]pyrazine-1,4-dione
90 23.11 154 5.03 Pyrrolizidine Antimicrobial
Antioxidant
Narasaiah et al., 2014; Ser et al., 2015a
(E)-5-Eicosene 95 23.32 280 5.07 Hydrocarbon Antimicrobial Elavarasi et al., 2014
3,5-dihydroxy-4,4-dimethyl-2,5-
cyclohexadien-1-one
81 24.08 154 3.60 Quinone No activity reported
Hexahydro-3-(2-methylpropyl)-
pyrrolo[1,2-a]pyrazine-1,4-dione
89 25.11, 25.17 210 9.04 Pyrrolizidine Antimicrobial Manimaran et al., 2015
(E)-9-Octadecene 94 25.47 252 2.21 Hydrocarbon Antimicrobial Cao et al., 2014; Okwu and Ighodaro,
2010
Trichloroacetic acid, hexadecyl
ester
87 27.42 387 1.03 Acid Cytotoxic,
Antioxidant
Luo et al., 2014
Hexahydro-3-(phenylmethyl)-
pyrrolo[1,2-a]pyrazine-1,4-dione
82 29.08 244 16.22 Pyrrolizidine Antimicrobial,
Nematicidal
Dashti et al., 2014; Wang et al., 2014
RT is retention time; MW is molecular weight of compounds.
FIGURE 9 | Scanning electron micrograph showing the effect of 1×MIC
EA-PB-52 against P. aeruginosa MTCC 741 (A) without treatment, (B)
treatment with EA-PB-52; and against C. albicans MTCC 227 (C)
without treatment, (D) treatment with EA-PB-52.
DISCUSSION
Actinomycetes remain as the most proliferant producers of small
molecule diversity including antimicrobials, diverse group of
enzymes and useful secondary metabolites with an incredible
variety of biological activities (Berdy, 2005). Depending on the
abundance of actinomycetes in the soil, 99% of the diverse
species has still been unexplored (Davies, 1999). Isolation of
these novel species from unexplored habitats increases the
possibility of discovery of new types of microbial products with
new types of activities. Many ecosystems have still been poorly
investigated and thus, there is a remarkable likelihood to exploit
novel microorganisms with diverse biological activities from
such ecosystems. There are several reports available regarding
the study of metabolic pathways leading to the production
of novel secondary metabolites from different microorganisms
exploited from untapped ecosystems (Glover, 1995; Tiwari
et al., 2014). Actinomycetes from diverse environments have
been explored in the last few decades for their capability to
produce a wide variety of natural bioactive compounds (Mitra
et al., 2008). Isolation of actinomycetes for the production of
antimicrobial secondary metabolites from the forest ecosystems
of Northeast India is reported by several researchers (Thakur
et al., 2007; Talukdar et al., 2012; Sharma et al., 2014; Passari
et al., 2015). After literature review, it has been found that
Pobitora Wildlife Sanctuary of Assam, India is an unexplored
ecosystem and no considerable data could be found regarding
bioactivity prospective of its microflora. Thus, we have an
additional advantage by isolating a Nocardia strain selectively
designated as PB-52 having broad spectrum bioactivity against
a wide range of pathogens including MRSA from this unexplored
habitat. Pobitora Wildlife Sanctuary is a part of the mega
biodiversity hotspot which indicates that it is a very dynamic
ecosystem where the occurrence of novel microflora may
be very likely (Myers et al., 2000). This study signifies the
first report on genus Nocardia isolated from this untouched
habitat.
Based on the comparative study of 16S rRNA gene sequence
and phylogenetic relationship, PB-52 strain lies in clade with N.
niigatensis IFM 0330 (NR_112195). PB-52 shared 99.7% sequence
similarity with type strain N. niigatensis IFM 0330 with 77
nucleotide differences, where PB-52 has a stretch of unique 64
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FIGURE 10 | Chemical structures of the identified compounds from
EA-PB-52.
nucleotides at 881 to 944 sites in themiddle of the sequence which
is absent in the typeNocardia strains included in the phylogenetic
tree. PB-52 differs from N. niigatensis IFM 0330 phenotypically
where PB-52 possess orange aerial mycelium with light brown
vegetative mycelium while N. niigatensis IFM 0330 (Kageyama
et al., 2004b) produced white aerial mycelium with orange-tan
vegetative mycelium. The spore surface of PB-52 was rugose
while N. niigatensis had smooth spore surface, PB-52 utilized
adonitol andmaltose whileN. niigatensis could not.N. niigatensis
could grow up to a maximum temperature of 37◦C while PB-52
grew up to 42◦C.
Nocardia strain PB-52 showed promising broad spectrum
antagonistic activity both in agar medium as well as in culture
broth against different bacteria and yeasts. Similar findings were
reported by a subset of the researchers (Kavitha et al., 2009,
2010; Mukai et al., 2009). The results signified that the bioactive
metabolites having antimicrobial activity were extracellular in
nature. Most of the bioactive secondary metabolites including
antibiotics produced by actinomycetes are previously reported
to be extracellular products (Augustine et al., 2005; Kumar P.
S. et al., 2014b). The results of antimicrobial activity of PB-
52 strain showed that it secretes broad spectrum antagonistic
metabolites which showed the capacity to inhibit the growth
of Gram-positive bacteria, Gram-negative bacteria, and Candida
species. These results are consistent with previous reports of
Sun et al. (2007) and Kavitha et al. (2009). The study for
evaluation of antimicrobial activity generally involves the search
of suitable culture medium. GLM was found to be the best
suitable medium for the growth and evaluation of antimicrobial
activity of Nocardia sp. PB-52 among the tested media. It was
obvious from the findings that the antimicrobial activity of PB-
52 was positively influenced by the presence of starch as carbon
and peptone as the nitrogen source in the medium. This result is
quite similar to the previously reported study of El-Gendy et al.
(2008) where it was shown that starch was the most suitable
carbon source for antibiotic production by Nocardia sp. ALAA
2000. It has also been shown that the production of antibiotics
in different organisms is strongly influenced by the nature of
carbon and nitrogen sources (Vilches et al., 1990). Extraction
of the culture broth of PB-52 strain using ethyl acetate led to
the recovery of EA-PB-52 consisting of a mixture of metabolites
which showed a wide range of activity against the selected
test microorganisms. El-Gendy et al. (2008) and Kavitha et al.
(2009) have also reported antimicrobial activity of ethyl acetate
extracted compound ofNocardia levisMK-VL_113 andNocardia
sp. ALAA 2000 respectively showing broad spectrum bioactivity.
It is essential to determine the efficiency of the organism
during its growth with different culture conditions for
determination of the factors that intensify the production
of antimicrobial compounds in culture media. PB-52 strain is
a mesophilic organism and its capacity of producing antibiotic
was consecutively increased with the increase in temperature
up to 28◦C and pH of 7.4 as well. Complete biosynthesis of
antimicrobial compounds production of PB-52 was established
on the 8th day of growth. Our result is consistent with the
findings of El-Gendy et al. (2008) who reported that Nocardia sp.
ALAA 2000 showed maximum growth and antibiotic production
at 28◦C, pH up to 7.4. As reported by Griffiths and Saker
(2003), Cylindrospermopsis raciboskii produced highest bioactive
metabolites when the bacteriummoved into the post-exponential
phase of growth, while Egorov (1985) suggested that highest
antagonistic potential was directly proportional to the value of
the biomass. These results signify that cultural environmental
aspects like temperature, pH, and incubation period have
profound influence on growth and antimicrobial potential of
Nocardia sp. PB-52 as reported in genus Nocardia by El-Gendy
et al. (2008).
Non-ribosomal peptides and polyketides are structurally
varied group of compounds and have significant biological roles
to play. Myriad of bioactive natural products belonging to these
two diverse groups have a wide range of applications in the field
ofmedicine, agriculture, and veterinary science (Cane andWalsh,
1999). PCR detection of genes encoding PKS-I and NRPS might
be responsible for both of their involvement in the regulation
of antimicrobial activity in PB-52. The result is comparable
with the studies of Ding et al. (2013) and Passari et al. (2015)
where it was clearly shown that few actinomycetes possessing
antimicrobial activity were positive for the presence of both of
these two biosynthetic pathway genes in their genome. Zhang
et al. (2014) also reported that antibacterial activity in Lysobacter
enzymogenes is regulated by the involvement of both a PKS and
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NRPS biosynthetic gene. This serves as useful information for
discovery of novel bioactive secondary metabolites from PB-52
strain.
MIC of EA-PB-52 at very low concentrations (as low as
0.975µg/mL) against all the test microorganisms supports the
popular notion that Nocardia can be one of the best source
of potent antimicrobial agents that can be of significance in
the treatment of infectious diseases especially those caused by
clinically resistant pathogens, such as MRSA, P. aeruginosa,
C. albicans etc. (Oskay et al., 2004). Our result is comparable
with the report of Kumar P. S. et al. (2014b) where the
crude ethyl acetate extracted product of Streptomyces lavendulae
strain SCA5 showed good antimicrobial activity against Gram-
positive and Gram-negative bacteria with the MIC-value of
125µg/mL and the MIC-value against fungi was reported
to be 31.25µg/mL. In addition, Teng_hern et al. (2015)
and Ser et al. (2015b) showed that the crude extract of
Streptomyces sp. MUM256 and S. pluripotens MUSC 137
respectively exhibited good antioxidant and anticancer property.
The effect of incubating the test microorganisms at 2 ×
MIC EA-PB-52 lead to rapid decrease in the average log
of the viable cells counts whose value was observed to be
higher than that treated with 1 × MICs. The considerable
decrease in cell counts between 4 and 8 h of incubation period
signifies that EA-PB-52 is highly bactericidal/fungicidal seeing
that the population of the test microorganisms were almost
totally wiped out after 8 h of incubation. Furthermore, the
net growth of all the test microorganisms was observed when
administered with ½× MICs of EA-PB-52. Growth inhibition
and efficiency of EA-PB-52 was ascertained to be dosage and
time-dependent which produces discrete time-kill profiles for the
tested microorganisms. Similar antimicrobial activity had also
been reported by Olajuyigbe and Afolayan (2012) and Singh et al.
(2014). The strong antimicrobial activity of EA-PB-52 was further
confirmed by SEM studies which lead to morphological changes
in the selected test microorganisms leading to shrinkage and
cytosolic loss of the cells. These results are in conformity with the
studies of Supaphon et al. (2013) and Nurkanto and Julistiono
(2014).
Actinomycetes are known to produce a wide variety of
bioactive secondary metabolites possessing diverse biological
activity. There are plentiful reports available incorporating
the study of GC-MS for chemical analysis of these microbial
metabolites (Jog et al., 2014; Teng_hern et al., 2015; Ser et al.,
2015a,b). For instance, study by Selvin et al. (2009) illustrated
several antimicrobial agents isolated from Nocardiopsis
dassonvilleiMAD08 by using GC-MS. Also, Kim et al. (2008) and
Ser et al. (2015a) reported the detection of bioactive compound
protocatechualdehyde and an antioxidative agent hexahydro-
pyrrolo[1,2-a]pyrazine-1,4-dione in the extract of S. lincolnensis
M-20 and S. mangrovisoli sp. nov., respectively with the help
of GC-MS. As such, in this study EA-PB-52 was subjected to
GC-MS analysis and twelve chemical compounds were detected
with different retention time and abundance. The identified
compounds comprised of phenolic compounds, pyrrolizidines,
quinones, hydrocarbons, esters, and acids. Phenolic compounds
are commonly known as potent antimicrobial agents as well
as antioxidant agents as they possess hydrogen-donating
capability to reduce free radicals (Yogeswari et al., 2012).
Recently, the study conducted by Kumar P. S. et al. (2014c)
showed highest antimicrobial activity in the GC-MS fractions
containing the highest amount of phenolic compounds. 3,5-bis
(1,1-dimethylethyl)-phenol and 2,4-di-t-butyl-6-nitrophenol
were the two phenolic compounds detected in EA-PB-52.
3,5-bis (1,1-dimethyethyl)-phenol constituted 34.43% of the
total constituents present in EA-PB-52. Antimicrobial activity
of 2,4-di-t-butyl-6-nitrophenol is already reported (Kumar P. S.
et al., 2014c) but there is no report of 3,5-bis (1,1-dimethyethyl)-
phenol as an antimicrobial agent. Roy et al. (2015) reported
surfactant activity of 3,5-bis (1,1-dimethyethyl)-phenol in
Nocardiopsis VITSISB isolated from Marina beach, India.
The pyrrolizidine compounds present in EA-PB-52 include
hexahydro-pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-
3-(2-methylpropyl)-pyrrolo[1,2-a]pyrazine-1,4-dione, and
hexahydro-3-(phenylmethyl)-pyrrolo[1,2-a]pyrazine-1,4-dione.
These compounds had been reported to possess promising
antimicrobial activity (Dashti et al., 2014; Manimaran et al.,
2015), nematicidal activity (Wang et al., 2014), and antioxidant
activity (Ser et al., 2015a). Another study conducted by Devi and
Wahab (2012) illustrated that hexahydro-3-(2-methylpropyl)-
pyrrolo[1,2-a]pyrazine-1,4-dione in endophytic fungi isolated
from Camellia sinensis possess strong antimicrobial activity.
Furthermore, a quinone compound, 3,5-dihydroxy-4,4-
dimethyl-2,5-cyclohexadien-1-one was detected in the PB-52
crude extract for which no antimicrobial activity has been
reported till now. Previous study by Sher (2009) demonstrated
that the antimicrobial effects of quinines are due to the fact
that they are known to complex with nucleophilic amino acids
in protein irreversibly. This often leads to loss of function and
inactivation of the protein. Asolkar et al. (2010) reported a
quinone antibiotic from Salinispora arenicola effective against
MRSA and other drug-resistant pathogens. Hydrocarbon
compounds such as (Z)-3-tetradecene, (E)-5-eicosene, and
(E)-9-octadecene are reported to possess antagonistic potential
against a wide range of pathogens by a subset of researchers (Cao
et al., 2014; Elavarasi et al., 2014; Natarajan and Dhas, 2014).
Manilal et al. (2009) reported antibacterial activity of dodecyl
acrylate produced by red algae, Falkenbergia hillebrandii against
multidrug resistant human pathogens. Antimicrobial activity of
(Z)-3-tridecene is not available till now. According to the recent
reports by Luo et al. (2014), trichloroacetic acid, hexadecyl ester
is reported to possess both antioxidant and anticancer activity
along with its antimicrobial nature. These compounds are well
recognized for their antimicrobial activity and together they may
be responsible for the broad spectrum antimicrobial activity
of EA-PB-52 against the wide range of test microorganisms.
Previous reports by Narayana et al. (2008), Selvin et al. (2009),
Ser et al. (2015a,b), and Teng_hern et al. (2015) demonstrated
the combinatorial effect of bioactive compounds from GC-MS
analysis. Thus, we propose that these compounds could be
the key contributing factor for the antimicrobial activities of
EA-PB-52. Further, the study of other biological activities of the
metabolites produced by the strain PB-52 is the subject of future
investigation.
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CONCLUSION
During the exploration of rare actinomycetes prevailing in
forest-derived soil samples of Pobitora Wildlife Sanctuary of
Assam, India, Nocardia sp. PB-52 was isolated by serial dilution
technique. Based on phenotypic and molecular characteristics,
the strain was identified as Nocardia sp. which shares 99.7%
sequence similarity with N. niigatensis IFM 0330 (NR_112195).
However, the differential phenotypic characteristics on agar
media and utilization of carbon sources mainly adonitol and
maltose reveal that the strain PB-52 may be classified within
the genus Nocardia as a different or novel species. Thus to
confirm it, further experiments are required such as cellular
fatty acid composition, DNA-DNA relatedness value, whole cell
sugar analysis etc. of strain PB-52 along with the closest species
N. niigatensis IFM 0330 and additional type strains.
Extracellular metabolite produced by PB-52 strain exhibited
a wide range of antimicrobial activity against Gram-positive
bacteria including MRSA, Gram-negative bacteria and yeasts.
The antimicrobial potential of Nocardia sp. PB-52 was positively
influenced by appropriate carbon and nitrogen supplements
in the GLM culture media along with the optimum cultural
conditions. GLM media constitute of starch and peptone as
the principal carbon and nitrogen sources respectively. The
maximum production of the antimicrobial compounds was
attained on the 8th day of growth at a temperature of 28◦C with
pH 7.4.
The antimicrobial activity of EA-PB-52 was further confirmed
by SEM studies where considerable morphological alterations
were observed in the test microbial pathogens. GC-MS analysis
revealed that the broad spectrum antimicrobial activity of
EA-PB-52 was due to the presence of biologically active
compounds. Twelve different compounds were detected in EA-
PB-52 which comprised of phenolic compounds, pyrrolizidines,
quinones, hydrocarbons, esters, and acids and some of them
are already reported to possess antimicrobial or other biological
activities. 3,5-bis (1,1-dimethylethyl)-phenol and 2,4-di-t-butyl-
6-nitrophenol were the two phenolic compounds detected in
EA-PB-52. Phenolic compounds are commonly known as potent
antimicrobial agents as well as antioxidant agents. Antimicrobial
activity of 2,4-di-t-butyl-6-nitrophenol is already documented
but 3,5-bis (1,1-dimethyethyl)-phenol is not reported as an
antimicrobial agent. As 3,5-bis (1,1-dimethyethyl)-phenol
occupied 34.43% of the total constituents present in EA-PB-52, it
might be involved in antimicrobial action.
The genus Nocardia was previously reported for the
production of antimicrobial compounds against microbial
pathogens. Mukai et al. (2009) reported nocardithiocin from
N. pseudobrasiliensis IFM 0757 active against Mycobacterium
and Gordonia species. Transvalencin A, an antifungal antibiotic
is produced from N. transvalensis IFM 10065 (Hoshino et al.,
2004). Kavitha et al. (2009) reported two bioactive compounds
bis-(2-ethylhexyl) phthalate and bis-(5-ethylheptyl) phthalate
from N. levis MK-VL_113 which showed antagonistic activity
against gram-positive bacteria, gram-negative bacteria, yeast,
and filamentous fungi. Celmer et al. (1980) reported that
N. argentinensis produced nargenicin A1 which was found to
be active against MRSA. In this work Nocardia sp. PB-52
isolated from the soil samples of Pobitora Wildlife Sanctuary,
Assam, India exhibited a wide range of antimicrobial activity
against Gram-positive bacteria including methicillin resistant
S. aureus (MRSA), Gram-negative bacteria and yeasts. However,
there is no report available regarding the antimicrobial activity
of N. niigatensis IFM 0330 (NR_112195) which is the closest
type strain of PB-52. From our results, it is evident that PB-
52 strain could be a promising candidate for the development
of potential antimicrobial drug active against a wide range of
microbial pathogens including drug resistant microorganisms
such as MRSA.
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